ABBV241213P260000
- 0.00
- 0.000.00%
AbbVie Newsroom
AbbVie Announces Leadership Change With New Appointment
Weekly Buzz: Tech stocks hit high scores on ominous day
AbbVie: David R. Purdue Will Be Senior Vice President, Controller
AbbVie: Kevin K. Buckbee, Senior Vice President, Controller, Plans to Retire From Controller Role Effective March 1
This Drugmaker's (ABBV) Parkinson's Medication Just Cleared A Key Hurdle – Is It Primed For A Monster Year In 2025?
Market Mixed on Friday the 13th | Livestock
AbbVie to Buy Nimble Therapeutics
AbbVie: Nimble Shareholders Eligible for Potential Development Milestone Payment >ABBV
Express News | Abbvie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline
AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline
Thursday Ends in Index Declines | Wall Street Today
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
Unlearn's 2024 Achievements Drive Innovation in AI for Clinical Development
Express News | Hungary's Richter CEO Says Previous Pace of Growth in Dividend Payouts Cannot Be Maintained
Express News | Hungary's Richter CEO Says Company Eyeing Acquisition Targets for Next Year
Express News | Hungary's Richter CEO Expects Slowdown in Sales Growth for Vraylar in 2025
Why AbbVie Inc. (ABBV) Is the Best Safe Stock to Buy According to Analysts?
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Press Release: AbbVie Completes Acquisition of Aliada Therapeutics
AbbVie Completes Acquisition Of Aliada Therapeutics >ABBV